NCT02179645View on ClinicalTrials.gov

GRC 27864 First in Man, Single Ascending Dose Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy
Interventions
DRUG

GRC 27864

DRUG

Celecoxib

DRUG

Placebo

Trial Locations (1)

LS2 9LH

Covance Clinical Research Unit, Leeds

Sponsors
All Listed Sponsors
collaborator

Glenmark Pharmaceuticals S.A.

INDUSTRY

lead

Glenmark Pharmaceuticals Ltd. India

INDUSTRY

NCT02179645 - GRC 27864 First in Man, Single Ascending Dose Study in Healthy Volunteers | Biotech Hunter | Biotech Hunter